AmBisome liposomal Innrennslisstofn, ördreifa 50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

ambisome liposomal innrennslisstofn, ördreifa 50 mg

gilead sciences ireland uc* - amphotericinum b inn - innrennslisstofn, ördreifa - 50 mg

Sporanox Hart hylki 100 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sporanox hart hylki 100 mg

janssen-cilag ab - itraconazolum inn - hart hylki - 100 mg

Methotrexate Pfizer (Methotrexate Wyeth) Tafla 2,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

methotrexate pfizer (methotrexate wyeth) tafla 2,5 mg

pfizer aps - methotrexatum inn - tafla - 2,5 mg

Lytgobi Evrópusambandið - íslenska - EMA (European Medicines Agency)

lytgobi

taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - antineoplastic lyfjum - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.